These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant. Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923 [TBL] [Abstract][Full Text] [Related]
45. Vaccine development against infection with Helicobacter pylori. Kleanthous H; Lee CK; Monath TP Br Med Bull; 1998; 54(1):229-41. PubMed ID: 9604446 [TBL] [Abstract][Full Text] [Related]
46. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice. Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589 [TBL] [Abstract][Full Text] [Related]
47. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Lee CK; Soike K; Giannasca P; Hill J; Weltzin R; Kleanthous H; Blanchard J; Monath TP Vaccine; 1999 Aug; 17(23-24):3072-82. PubMed ID: 10462242 [TBL] [Abstract][Full Text] [Related]
49. How far are we from vaccination against Helicobacter pylori infection? Stubljar D; Jukic T; Ihan A Expert Rev Vaccines; 2018 Oct; 17(10):935-945. PubMed ID: 30238819 [TBL] [Abstract][Full Text] [Related]
50. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. Akhiani AA; Stensson A; Schön K; Lycke N Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008 [TBL] [Abstract][Full Text] [Related]
51. Gastric Subserous Vaccination With Liu W; Zeng Z; Luo S; Hu C; Xu N; Huang A; Zheng L; Sundberg EJ; Xi T; Xing Y Front Immunol; 2019; 10():1115. PubMed ID: 31156652 [TBL] [Abstract][Full Text] [Related]
52. Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Milani M; Sharifi Y; Rahmati-Yamchi M; Somi MH; Akbarzadeh A Expert Rev Vaccines; 2015 Jun; 14(6):833-40. PubMed ID: 25645086 [TBL] [Abstract][Full Text] [Related]
53. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine. Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori. Skene CD; Doidge C; Sutton P Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687 [TBL] [Abstract][Full Text] [Related]
55. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971 [TBL] [Abstract][Full Text] [Related]
57. The current status of Helicobacter pylori vaccines: a review. Kabir S Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745 [TBL] [Abstract][Full Text] [Related]
59. Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant. Hitzler I; Oertli M; Becher B; Agger EM; Müller A Gastroenterology; 2011 Jul; 141(1):186-96, 196.e1. PubMed ID: 21569773 [TBL] [Abstract][Full Text] [Related]
60. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model. Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]